The Company

Eutropics Pharmaceuticals develops more effective and less toxic cancer therapies that hit targets essential for cancer cell survival. By apoptosis – Programmed Cell Death – damaged cells commit suicide and are removed before they can become cancerous.

Cancer cells survive due to blocks that prevent apoptosis: the drugs Eutropics Pharmaceuticals is developing trigger cell death in cancer cells that otherwise elude control.

A unique and powerful assay guides clinicians in the use of the drugs. The assay establishes where apoptosis is blocked and if the specific protein that our treatment targets is the cause. This tells clinicians in advance which patients will respond to the treatment, a critical companion to our therapeutic.

Disease targets include blood cancers, small cell lung cancers and ovarian cancer.